搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Moorella thermoacetica 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP646975MUG
CSB-EP646975MUG
CSB-BP646975MUG
CSB-MP646975MUG
CSB-EP646975MUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Moorella thermoacetica (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase (fabZ) CSB-YP646976MUG
CSB-EP646976MUG
CSB-BP646976MUG
CSB-MP646976MUG
CSB-EP646976MUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Moorella thermoacetica 50S ribosomal protein L9 (rplI) CSB-YP646977MUG
CSB-EP646977MUG
CSB-BP646977MUG
CSB-MP646977MUG
CSB-EP646977MUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Moorella thermoacetica Peptidyl-tRNA hydrolase (pth) CSB-YP646978MUG
CSB-EP646978MUG
CSB-BP646978MUG
CSB-MP646978MUG
CSB-EP646978MUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Moorella thermoacetica Glutamine amidotransferase subunit pdxT (pdxT) CSB-YP646979MUG
CSB-EP646979MUG
CSB-BP646979MUG
CSB-MP646979MUG
CSB-EP646979MUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Translation initiation factor IF-2 (infB), partial CSB-YP646980RMB
CSB-EP646980RMB
CSB-BP646980RMB
CSB-MP646980RMB
CSB-EP646980RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 50S ribosomal protein L25 (rplY) CSB-YP646981RMB
CSB-EP646981RMB
CSB-BP646981RMB
CSB-MP646981RMB
CSB-EP646981RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP646982RMB
CSB-EP646982RMB
CSB-BP646982RMB
CSB-MP646982RMB
CSB-EP646982RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Protein-export protein SecB (secB) CSB-YP646983RMB
CSB-EP646983RMB
CSB-BP646983RMB
CSB-MP646983RMB
CSB-EP646983RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Putative pterin-4-alpha-carbinolamine dehydratase (Rru_A3581) CSB-YP646984RMB
CSB-EP646984RMB
CSB-BP646984RMB
CSB-MP646984RMB
CSB-EP646984RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP646985RMB
CSB-EP646985RMB
CSB-BP646985RMB
CSB-MP646985RMB
CSB-EP646985RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum UPF0042 nucleotide-binding protein Rru_A3448 (Rru_A3448) CSB-YP646986RMB
CSB-EP646986RMB
CSB-BP646986RMB
CSB-MP646986RMB
CSB-EP646986RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Probable GTP-binding protein EngB (engB) CSB-YP646987RMB
CSB-EP646987RMB
CSB-BP646987RMB
CSB-MP646987RMB
CSB-EP646987RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Homoserine O-acetyltransferase (metX) CSB-YP646988RMB
CSB-EP646988RMB
CSB-BP646988RMB
CSB-MP646988RMB
CSB-EP646988RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Ribonuclease HII (rnhB) CSB-YP646989RMB
CSB-EP646989RMB
CSB-BP646989RMB
CSB-MP646989RMB
CSB-EP646989RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP646990RMB
CSB-EP646990RMB
CSB-BP646990RMB
CSB-MP646990RMB
CSB-EP646990RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP646991RMB
CSB-EP646991RMB
CSB-BP646991RMB
CSB-MP646991RMB
CSB-EP646991RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Alanine--tRNA ligase (alaS), partial CSB-YP646992RMB
CSB-EP646992RMB
CSB-BP646992RMB
CSB-MP646992RMB
CSB-EP646992RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum Maf-like protein Rru_A2768 (Rru_A2768) CSB-YP646993RMB
CSB-EP646993RMB
CSB-BP646993RMB
CSB-MP646993RMB
CSB-EP646993RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodospirillum rubrum 50S ribosomal protein L7/L12 (rplL) CSB-YP646994RMB
CSB-EP646994RMB
CSB-BP646994RMB
CSB-MP646994RMB
CSB-EP646994RMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>